Literature DB >> 9603967

Analysis of the Gs/mitogen-activated protein kinase pathway in mutant S49 cells.

Y Wan1, X Y Huang.   

Abstract

Heterotrimeric G protein-coupled receptors can activate the mitogen-activated protein kinase (MAPK) cascade. Recent studies using pharmacological inhibitors or dominant-negative mutants of signaling molecules have advanced our understanding of the pathways from G protein-coupled receptors to MAPK. However, molecular genetic analysis of these pathways is inadequate in mammalian cells. Here, using the well characterized Gsalpha- and protein kinase A-deficient S49 mouse lymphoma cells, we provide the molecular genetic evidence that Gsalpha is responsible for transducing the beta-adrenergic receptor signal to MAPK in a protein kinase A-dependent pathway involving Rap1 and Raf (but not Ras) molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603967     DOI: 10.1074/jbc.273.23.14533

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expression.

Authors:  Hesham A Tawfeek; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

2.  Bombyx adipokinetic hormone receptor activates extracellular signal-regulated kinase 1 and 2 via G protein-dependent PKA and PKC but β-arrestin-independent pathways.

Authors:  Haishan Huang; Xiaobai He; Xiaoyan Deng; Guo Li; Guoyuan Ying; Yi Sun; Liangen Shi; Jeffrey L Benovic; Naiming Zhou
Journal:  Biochemistry       Date:  2010-12-02       Impact factor: 3.162

3.  Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.

Authors:  L M Luttrell; F L Roudabush; E W Choy; W E Miller; M E Field; K L Pierce; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

4.  CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1.

Authors:  K D Carey; T J Dillon; J M Schmitt; A M Baird; A D Holdorf; D B Straus; A S Shaw; P J Stork
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Glucagon receptor activates extracellular signal-regulated protein kinase 1/2 via cAMP-dependent protein kinase.

Authors:  Y Jiang; A M Cypess; E D Muse; C R Wu; C G Unson; R B Merrifield; T P Sakmar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

6.  Nociceptor sensitization by extracellular signal-regulated kinases.

Authors:  K O Aley; A Martin; T McMahon; J Mok; J D Levine; R O Messing
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

7.  Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1.

Authors:  J M Schmitt; P J Stork
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

8.  Ser/ Thr residues at α3/β5 loop of Gαs are important in morphine-induced adenylyl cyclase sensitization but not mitogen-activated protein kinase phosphorylation.

Authors:  Mohammad Seyedabadi; Seyed Nasser Ostad; Paul R Albert; Ahmad R Dehpour; Reza Rahimian; Mahmoud Ghazi-Khansari; Mohammad H Ghahremani
Journal:  FEBS J       Date:  2012-01-13       Impact factor: 5.542

9.  Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.

Authors:  J Garcia; J de Gunzburg; A Eychène; S Gisselbrecht; F Porteu
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

10.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.